Suppr超能文献

半同种异体树突状细胞可诱导抗原特异性T细胞活化,同时存在的同种异体反应性并不会增强这种活化。

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.

作者信息

Wells James W, Cowled Chris J, Darling David, Guinn Barbara-Ann, Farzaneh Farzin, Noble Alistair, Galea-Lauri Joanna

机构信息

Department of Haematological and Molecular Medicine, King's College London, The Rayne Institute, London, SE5 9NU, UK.

出版信息

Cancer Immunol Immunother. 2007 Dec;56(12):1861-73. doi: 10.1007/s00262-007-0328-x. Epub 2007 May 9.

Abstract

BACKGROUND

Alloreactive T-cell responses are known to result in the production of large amounts of proinflammatory cytokines capable of activating and maturing dendritic cells (DC). However, it is unclear whether these allogeneic responses could also act as an adjuvant for concurrent antigen-specific responses.

OBJECTIVE

To examine effects of simultaneous alloreactive and antigen-specific T-cell responses induced by semi-allogeneic DC.

METHODS

Semi-allogeneic DC were generated from the F(1) progeny of inbred strains of mice (C57BL/6 and C3H, or C57BL/6 and DBA). We directly primed antigen-specific CD8(+) and CD4(+) T-cells from OT-I and OT-II mice, respectively, in the absence of allogeneic responses, in vitro, and in the presence or absence of alloreactivity in vivo.

RESULTS

In vitro, semi-allogeneic DC cross-presented ovalbumin (OVA) to naïve CD8(+) OT-I transgenic T-cells, primed naïve CD4(+) OT-II transgenic T-cells and could stimulate strong alloreactive T-cell proliferation in a primary mixed lymphocyte reaction (MLR). In vivo, semi-allogeneic DC migrated efficiently to regional lymph nodes but did not survive there as long as autologous DC. In addition, they were not able to induce cytotoxic T-lymphocyte (CTL) activity to a target peptide, and only weakly stimulated adoptively transferred OT-II cells. The CD4(+) response was unchanged in allo-tolerized mice, indicating that alloreactive T-cell responses could not provide help for concurrently activated antigen-specific responses. In an EL4 tumour-treatment model, vaccination with semi-allogeneic DC/EL4 fusion hybrids, but not allogeneic DC/EL4 hybrids, significantly increased mouse survival.

CONCLUSION

Expression of self-Major histocompatibility complex (MHC) by semi-allogeneic DC can cause the induction of antigen-specific immunity, however, concurrently activated allogeneic bystander responses do not provide helper or adjuvant effects.

摘要

背景

已知同种异体反应性T细胞应答会导致产生大量能够激活和成熟树突状细胞(DC)的促炎细胞因子。然而,尚不清楚这些同种异体反应是否也能作为同时发生的抗原特异性应答的佐剂。

目的

研究半同种异体DC诱导的同种异体反应性和抗原特异性T细胞应答同时发生的效应。

方法

半同种异体DC由近交系小鼠(C57BL/6和C3H,或C57BL/6和DBA)的F1子代产生。我们分别在体外无同种异体反应的情况下,以及在体内有或无同种异体反应的情况下,直接启动来自OT-I和OT-II小鼠的抗原特异性CD8(+)和CD4(+) T细胞。

结果

在体外,半同种异体DC将卵清蛋白(OVA)交叉呈递给未致敏的CD8(+) OT-I转基因T细胞,启动未致敏的CD4(+) OT-II转基因T细胞,并能在初次混合淋巴细胞反应(MLR)中刺激强烈的同种异体反应性T细胞增殖。在体内,半同种异体DC有效地迁移至局部淋巴结,但在那里的存活时间不如自体DC长。此外,它们不能诱导针对靶肽的细胞毒性T淋巴细胞(CTL)活性,对过继转移的OT-II细胞的刺激也很弱。在同种异体耐受小鼠中,CD4(+)应答未改变,表明同种异体反应性T细胞应答不能为同时激活的抗原特异性应答提供帮助。在EL4肿瘤治疗模型中,用半同种异体DC/EL4融合杂种疫苗接种,但同种异体DC/EL4杂种疫苗接种则不能,显著提高了小鼠存活率。

结论

半同种异体DC表达自身主要组织相容性复合体(MHC)可诱导抗原特异性免疫,但同时激活的同种异体旁观者应答不提供辅助或佐剂效应。

相似文献

引用本文的文献

2
Dendritic cell-based immunotherapy.基于树突状细胞的免疫疗法。
Cell Res. 2017 Jan;27(1):74-95. doi: 10.1038/cr.2016.157. Epub 2016 Dec 27.
6
Regulation of tumor immunity by tumor/dendritic cell fusions.肿瘤/树突状细胞融合对肿瘤免疫的调节
Clin Dev Immunol. 2010;2010:516768. doi: 10.1155/2010/516768. Epub 2010 Oct 26.
7
Cancer vaccine by fusions of dendritic and cancer cells.通过树突状细胞与癌细胞融合制备癌症疫苗。
Clin Dev Immunol. 2009;2009:657369. doi: 10.1155/2009/657369. Epub 2010 Feb 18.

本文引用的文献

1
The second international meeting on allogeneic transplantation in solid tumors.第二届实体瘤同种异体移植国际会议
Bone Marrow Transplant. 2006 Oct;38(8):527-37. doi: 10.1038/sj.bmt.1705479. Epub 2006 Sep 4.
4
Exploiting beneficial alloreactive T cells.利用有益的同种异体反应性T细胞。
Vox Sang. 2006 Jul;91(1):20-7. doi: 10.1111/j.1423-0410.2006.00775.x.
6
Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer.
Biol Blood Marrow Transplant. 2006 Mar;12(3):346-54. doi: 10.1016/j.bbmt.2005.10.028.
7
Human dendritic cell subsets for vaccination.用于疫苗接种的人类树突状细胞亚群。
J Clin Immunol. 2005 Nov;25(6):551-72. doi: 10.1007/s10875-005-8216-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验